The popular acne drug, isotretinoin, is not a specific risk factor for depression or mood disorders as previously thought, according to a large study of more than 38,000 patients. The study, conducted by researchers at Northwestern University Feinberg School of Medicine in Chicago was presented at the 2019 American Academy of Dermatology Annual Meeting in March.
